Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID	DTD0003 Transporter Info
Gene Name	ABCB1
Transporter Name	P-glycoprotein 1
Gene ID	5243
UniProt ID	P08183

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains
Class 1.1: Basic leucine zipper factors		Click to Show/Hide the Full List of 5 TF(s) Regulating This DT
CEBPB		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[1]
TF Protein Name	CCAAT/enhancer-binding protein beta		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	CCAAT/enhancer-binding protein beta (CEBPB) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
HLF		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[2]
TF Protein Name	Hepatic leukemia factor		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	C57BL/6J mice
Detailed Description	Hepatic leukemia factor (HLF) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
JUN		Click to Show/Hide to Show 4 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[3]
TF Protein Name	Transcription factor Jun		Transcription Factor Info
Affected Drug/Substrate	Adriamycin; Vinblastine; Paclitaxel
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Transcription factor Jun (JUN) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in colorectal cancer condition			[4]
TF Protein Name	Transcription factor Jun		Transcription Factor Info
Affected Drug/Substrate	Vincristine
Studied Phenotype	Colorectal cancer [ICD11: 2B91]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colorectal cancer cells (HCT8)
Detailed Description	Transcription factor Jun (JUN), influenced by the exogenous nS-398, has been reported to activate the transcription of ABCB1 gene in colorectal cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Repression of ABCB1 gene in chronic myelogenous leukaemia condition			[5]
TF Protein Name	Transcription factor Jun		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Chronic myelogenous leukaemia [ICD11: 2A20.0]
Tissue	Blood
Related DT Changes	Down regulating
Experimental Material	Human blast phase chronic myelogenous leukemia, BCR-ABL1 positive cells (K562)
Detailed Description	Transcription factor Jun (JUN) has been reported to repress the transcription of ABCB1 gene in chronic myelogenous leukaemia condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 4	Repression of ABCB1 gene in lung squamous cell cancer condition			[6]
TF Protein Name	Transcription factor Jun		Transcription Factor Info
Affected Drug/Substrate	Adriamycin; Daunomycin
Studied Phenotype	Lung squamous cell cancer [ICD11: 2C25.2]
Tissue	Lung
Related DT Changes	Down regulating
Experimental Material	Human lung squamous cell carcinoma cells (SK-MES-1)
Detailed Description	Transcription factor Jun (JUN) has been reported to repress the transcription of ABCB1 gene in lung squamous cell cancer condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
NFE2L2		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in health condition			[7]
TF Protein Name	Nuclear factor erythroid 2-related factor 2		Transcription Factor Info
Studied Phenotype	Heallth [ICD11: N.A]
Tissue	Liver
Related DT Changes	up regulating
Experimental Material	C57BL/6 mice
Detailed Description	Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous hydrogen peroxide, has been reported to activate the transcription of ABCB1 gene in health condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in colon cancer condition			[8]
TF Protein Name	Nuclear factor erythroid 2-related factor 2		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	Nuclear factor erythroid 2-related factor 2 (NFE2L2), influenced by the exogenous hydrogen peroxide, has been reported to activate the transcription of ABCB1 gene in colon cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
NFIL3		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in colon cancer condition			[2]
TF Protein Name	Nuclear factor interleukin-3-regulated protein		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Down regulating
Experimental Material	C57BL/6J mice
Detailed Description	Nuclear factor interleukin-3-regulated protein (NFIL3) has been reported to repress the transcription of ABCB1 gene in colon cancer condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Class 1.2: Basic helix-loop-helix factors		Click to Show/Hide the Full List of 5 TF(s) Regulating This DT
AHR		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in health condition			[9]
TF Protein Name	Aryl hydrocarbon receptor		Transcription Factor Info
Studied Phenotype	Heallth [ICD11: N.A]
Tissue	Kidney
Related DT Changes	up regulating
Experimental Material	Killifish renal proximal tubule cells
Detailed Description	Aryl hydrocarbon receptor (AHR), influenced by the exogenous polychlorinated dibenzodioxin, has been reported to activate the transcription of ABCB1 gene in health condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
BHLHE40		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCA1 gene in chronic myelogenous leukaemia condition			[10]
TF Protein Name	Class E basic helix-loop-helix protein 40		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Chronic myelogenous leukaemia [ICD11: 2A20.0]
Tissue	Blood
Related DT Changes	Down regulating
Experimental Material	Human blast phase chronic myelogenous leukemia, BCR-ABL1 positive cells (K562)
Detailed Description	Class E basic helix-loop-helix protein 40 (BHLHE40) has been reported to repress the transcription of ABCB1 gene in chronic myelogenous leukaemia condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Repression of ABCA1 gene in breast cancer condition			[10]
TF Protein Name	Class E basic helix-loop-helix protein 40		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Down regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Class E basic helix-loop-helix protein 40 (BHLHE40) has been reported to repress the transcription of ABCB1 gene in breast cancer condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
HIF1A		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[11]
TF Protein Name	Hypoxia-inducible factor 1-alpha		Transcription Factor Info
Affected Drug/Substrate	Digoxin; Adriamycin
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (T84)
Detailed Description	Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in ovarian serous adenocarcinoma condition			[12]
TF Protein Name	Hypoxia-inducible factor 1-alpha		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel
Studied Phenotype	Ovarian serous adenocarcinoma [2C73.02]
Tissue	Ovary
Related DT Changes	up regulating
Experimental Material	Human ovarian serous adenocarcinoma cells (Caov-3)
Detailed Description	Hypoxia-inducible factor 1-alpha (HIF1A), influenced by the exogenous topotecan, has been reported to activate the transcription of ABCB1 gene in ovarian serous adenocarcinoma condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
MYCN		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in brain neuroblastoma condition			[13]
TF Protein Name	N-myc proto-oncogene protein		Transcription Factor Info
Affected Drug/Substrate	Cis-platin; Etoposide
Studied Phenotype	Brain neuroblastoma [ICD11: 2A00.11]
Tissue	Brain
Related DT Changes	Up regulating
Experimental Material	BALB/c athymic Nu/Nu mice
Detailed Description	N-myc proto-oncogene protein (MYCN) has been reported to activate the transcription of ABCB1 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TCF4		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[14]
TF Protein Name	Transcription factor 4		Transcription Factor Info
Affected Drug/Substrate	Doxycycline
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (DLD-1)
Detailed Description	Transcription factor 4 (TCF4) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in cadmium poision condition			[15]
TF Protein Name	Transcription factor 4		Transcription Factor Info
Studied Phenotype	Cadmium poision [ICD11: NE61]
Tissue	Kidney
Related DT Changes	Up regulating
Experimental Material	Rat Kidney cells (WKPT-0293 Cl.2)
Detailed Description	Transcription factor 4 (TCF4) has been reported to activate the transcription of ABCB1 gene in cadmium poision condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TF Superclass 2: Zinc-coordinating DNA-binding domains
Class 2.1: Nuclear receptors with C4 zinc fingers		Click to Show/Hide the Full List of 5 TF(s) Regulating This DT
ESR1		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[16]
TF Protein Name	Estrogen receptor		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon adenocarcinoma cells (LS180)
Detailed Description	Estrogen receptor (ESR1), influenced by the exogenous estrone, has been reported to activate the transcription of ABCB1 gene in colon cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in colon cancer condition			[16]
TF Protein Name	Estrogen receptor		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon adenocarcinoma cells (LS180)
Detailed Description	Estrogen receptor (ESR1), influenced by the exogenous estrone, has been reported to activate the transcription of ABCB1 gene in colon cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
NR1I2		Click to Show/Hide to Show 7 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[17]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Affected Drug/Substrate	Adriamycin; Vincristine; Vinblastine; Cyclophosphamide; Ifosfamide
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (LS180)
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in breast cancer condition			[18]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	up regulating
Experimental Material	Human breast adenocarcinoma cells (MDA-MB-231)
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the dietary food metabolite from Host unspecified microbiota, has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Activation of ABCB1 gene in colon cancer condition			[17]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Affected Drug/Substrate	Doxorubicin
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon adenocarcinoma cells (LS180)
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the dietary food metabolite from Host unspecified microbiota, has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 4	Activation of ABCB1 gene in colon cancer condition			[19]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Affected Drug/Substrate	Diltiazem
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon adenocarcinoma cells (Caco-2)
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the dietary food metabolite from Host unspecified microbiota, has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 5	Activation of ABCB1 gene in cholestatic liver disease condition			[20]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Studied Phenotype	Cholestatic liver disease [ICD11: DB99]
Tissue	Liver
Related DT Changes	Up regulating
Experimental Material	C57BL/6 mice
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2) has been reported to activate the transcription of ABCB1 gene in cholestatic liver disease condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 6	Activation of ABCB1 gene in health condition			[21]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Studied Phenotype	Heallth [ICD11: N.A]
Tissue	Intestine
Related DT Changes	up regulating
Experimental Material	Sprague-Dawley rats
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the dietary food metabolite from Host unspecified microbiota, has been reported to activate the transcription of ABCB1 gene in health condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 7	Activation of ABCB1 gene in hepatoblastoma condition			[22]
TF Protein Name	Nuclear receptor subfamily 1 group I member 2		Transcription Factor Info
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Tissue	Liver
Related DT Changes	up regulating
Experimental Material	Human hepatoblastoma cells (HepG2)
Detailed Description	Nuclear receptor subfamily 1 group I member 2 (NR1I2), influenced by the dietary food metabolite from Host unspecified microbiota, has been reported to activate the transcription of ABCB1 gene in hepatoblastoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
NR1I3		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[23]
TF Protein Name	Nuclear receptor subfamily 1 group I member 3		Transcription Factor Info
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	human intestine tissue isolates
Detailed Description	Nuclear receptor subfamily 1 group I member 3 (NR1I3) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
NR3C1		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in gestational choriocarcinoma condition			[24]
TF Protein Name	Glucocorticoid receptor		Transcription Factor Info
Studied Phenotype	Gestational choriocarcinoma [ICD11: 2C75]
Tissue	Trophoderm
Related DT Changes	Up regulating
Experimental Material	Human cytotrophoblast cell isolates
Detailed Description	Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of ABCB1 gene in gestational choriocarcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in brain edema condition			[25]
TF Protein Name	Glucocorticoid receptor		Transcription Factor Info
Studied Phenotype	Brain edema [ICD11: 8D60.1]
Tissue	Brain
Related DT Changes	Up regulating
Experimental Material	Sprague-Dawley rats
Detailed Description	Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of ABCB1 gene in brain edema condition, which leads to an enhanced function of the drug transporter P-glycoprotein 1.
PPARG		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in ovarian endometrioid adenocarcinoma condition			[26]
TF Protein Name	Peroxisome proliferator-activated receptor gamma		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel
Studied Phenotype	Ovarian endometrioid adenocarcinoma [ICD11: 2C73.01]
Tissue	Ovary
Related DT Changes	down regulating
Experimental Material	Human ovarian endometrioid adenocarcinoma cells (A2780)
Detailed Description	Peroxisome proliferator-activated receptor gamma (PPARG), influenced by the exogenous rosiglitazone, has been reported to repress the transcription of ABCB1 gene in ovarian endometrioid adenocarcinoma condition , which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Class 2.2: Other C4 zinc finger-type factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
GATA2		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Direct binding to ABCB1 gene			[27]
TF Protein Name	Endothelial transcription factor GATA-2		Transcription Factor Info
Tissue	Blood
Related DT Changes	Direct regulating
Experiment method	TF-transporter regulations were collected from ChIP-Seq datasets.
Detailed Description	Endothelial transcription factor GATA-2 (GATA2) can directly bind to the ABCB1 gene, which in turn affects the expression or function of the drug transporter P-glycoprotein 1.
Class 2.3: C2H2 zinc finger factors		Click to Show/Hide the Full List of 4 TF(s) Regulating This DT
EGR1		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[28]
TF Protein Name	Early growth response protein 1		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Early growth response protein 1 (EGR1) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in chronic myelogenous leukaemia condition			[29]
TF Protein Name	Early growth response protein 1		Transcription Factor Info
Studied Phenotype	Chronic myelogenous leukaemia [ICD11: 2A20.0]
Tissue	Blood
Related DT Changes	Up regulating
Experimental Material	Human blast phase chronic myelogenous leukemia, BCR-ABL1 positive cells (K562)
Detailed Description	Early growth response protein 1 (EGR1) has been reported to activate the transcription of ABCB1 gene in chronic myelogenous leukaemia condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
GLIS1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Direct binding to ABCB1 gene			[30]
TF Protein Name	Zinc finger protein GLIS1		Transcription Factor Info
Tissue	Blood; Colon
Related DT Changes	Direct regulating
Experiment method	TF-transporter regulations were collected from ChIP-Seq datasets.
Detailed Description	Zinc finger protein GLIS1 (GLIS1) can directly bind to the ABCB1 gene, which in turn affects the expression or function of the drug transporter P-glycoprotein 1.
SP1		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in epidermoid carcinoma condition			[31]
TF Protein Name	Transcription factor Sp1		Transcription Factor Info
Studied Phenotype	Epidermoid carcinoma [ICD11: 2C31]
Tissue	Cervix
Related DT Changes	Up regulating
Experimental Material	Human human papillomavirus-related endocervical adenocarcinoma cells (KB-3-1)
Detailed Description	Transcription factor Sp1 (SP1) has been reported to activate the transcription of ABCB1 gene in epidermoid carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in cervical cancer condition			[32]
TF Protein Name	Transcription factor Sp1		Transcription Factor Info
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Tissue	Cervix
Related DT Changes	Up regulating
Experimental Material	Human human papillomavirus-related endocervical adenocarcinoma cells (KB-8-5)
Detailed Description	Transcription factor Sp1 (SP1) has been reported to activate the transcription of ABCB1 gene in cervical cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
WT1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in chronic myelogenous leukaemia condition			[33]
TF Protein Name	Wilms tumor protein		Transcription Factor Info
Studied Phenotype	Chronic myelogenous leukaemia [ICD11: 2A20.0]
Tissue	Blood
Related DT Changes	Down regulating
Experimental Material	Human blast phase chronic myelogenous leukemia, BCR-ABL1 positive cells (K562)
Detailed Description	Wilms tumor protein (WT1) has been reported to repress the transcription of ABCB1 gene in chronic myelogenous leukaemia condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Class 2.6: CXXC zinc finger factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
KMT2A		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in acute lymphoblastic leukemia condition			[34]
TF Protein Name	Histone-lysine N-methyltransferase 2A		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel; Vinblastine; Daunomycin
Studied Phenotype	T acute lymphoblastic leukemia [ICD11: 2A90]
Tissue	Blood
Related DT Changes	Up regulating
Experimental Material	Human childhood T acute lymphoblastic leukemia cells (Jurkat)
Detailed Description	Histone-lysine N-methyltransferase 2A (KMT2A) has been reported to activate the transcription of ABCB1 gene in acute lymphoblastic leukemia condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TF Superclass 3: Helix-turn-helix domains
Class 3.1: Homeo domain factors		Click to Show/Hide the Full List of 2 TF(s) Regulating This DT
CDX2		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[35]
TF Protein Name	Homeobox protein CDX-2		Transcription Factor Info
Affected Drug/Substrate	Vincristine; Paclitaxel
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (HT-29)
Detailed Description	Homeobox protein CDX-2 (CDX2) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in colorectal cancer condition			[36]
TF Protein Name	Homeobox protein CDX-2		Transcription Factor Info
Affected Drug/Substrate	5-fluorouracil
Studied Phenotype	Colorectal cancer [ICD11: 2B91]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	human colon cancer cell isolates
Detailed Description	Homeobox protein CDX-2 (CDX2) has been reported to activate the transcription of ABCB1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
PITX2		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in renal cell cancer condition			[37]
TF Protein Name	Pituitary homeobox 2		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Renal cell cancer [ICD11: 2C90]
Tissue	Kidney
Related DT Changes	Up regulating
Experimental Material	Human renal cell carcinoma cells (A498)
Detailed Description	Pituitary homeobox 2 (PITX2) has been reported to activate the transcription of ABCB1 gene in renal cell cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Class 3.3: Fork head / winged helix factors		Click to Show/Hide the Full List of 2 TF(s) Regulating This DT
E2F1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in glioblastoma condition			[38]
TF Protein Name	Transcription factor E2F1		Transcription Factor Info
Affected Drug/Substrate	Colchicine; Methyl-methanesulfonate; Etoposide; Nocodazole
Studied Phenotype	Glioblastoma [ICD11: 2A00.00]
Tissue	Brain
Related DT Changes	Up regulating
Experimental Material	Human glioblastoma cells (T98G)
Detailed Description	Transcription factor E2F1 (E2F1) has been reported to activate the transcription of ABCB1 gene in glioblastoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
FOXO1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[39]
TF Protein Name	Forkhead box protein O1		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Forkhead box protein O1 (FOXO1) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Class 3.4: Heat shock factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
HSF1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in cervical cancer condition			[40]
TF Protein Name	Heat shock factor protein 1		Transcription Factor Info
Affected Drug/Substrate	Vinblastine
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Tissue	Cervix
Related DT Changes	Up regulating
Experimental Material	Human human papillomavirus-related endocervical adenocarcinoma cells (HeLa)
Detailed Description	Heat shock factor protein 1 (HSF1) has been reported to activate the transcription of ABCB1 gene in cervical cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Class 3.5: Tryptophan cluster factors		Click to Show/Hide the Full List of 3 TF(s) Regulating This DT
ETS1		Click to Show/Hide to Show 3 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[41]
TF Protein Name	Protein C-ets-1		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel; Docetaxel; Vincristine; Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Protein C-ets-1 (ETS1) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in osteosarcoma condition			[42]
TF Protein Name	Protein C-ets-1		Transcription Factor Info
Studied Phenotype	Osteosarcoma [ICD11: 2B51]
Tissue	Bone
Related DT Changes	Up regulating
Experimental Material	Human osteosarcoma cells (Saos-2)
Detailed Description	Protein C-ets-1 (ETS1) has been reported to activate the transcription of ABCB1 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Repression of ABCB1 gene in cervical cancer condition			[43]
TF Protein Name	Protein C-ets-1		Transcription Factor Info
Studied Phenotype	Cervical cancer [ICD11: 2C77]
Tissue	Cervix
Related DT Changes	Down regulating
Experimental Material	Human cervical squamous cell carcinoma, not otherwise specified cells (C33)
Detailed Description	Protein C-ets-1 (ETS1) has been reported to repress the transcription of ABCB1 gene in cervical cancer condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
FLI1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Direct binding to ABCB1 gene			[44]
TF Protein Name	Friend leukemia integration 1 transcription factor		Transcription Factor Info
Tissue	Blood; Mesenchymal; Vein
Related DT Changes	Direct regulating
Experiment method	TF-transporter regulations were collected from ChIP-Seq datasets.
Detailed Description	Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the ABCB1 gene, which in turn affects the expression or function of the drug transporter P-glycoprotein 1.
IRF1		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in gastric adenocarcinoma condition			[45]
TF Protein Name	Interferon regulatory factor 1		Transcription Factor Info
Studied Phenotype	Gastric adenocarcinoma [ICD11: 2B72.0]
Tissue	Stomach
Related DT Changes	down regulating
Experimental Material	Human gastric adenocarcinoma cells (MKN45)
Detailed Description	Interferon regulatory factor 1 (IRF1), influenced by the exogenous doxycycline, has been reported to repress the transcription of ABCB1 gene in gastric adenocarcinoma condition , which leads to a decreased expression of the drug transporter P-glycoprotein 1.
TF Superclass 4: Other all-alpha-helical DNA-binding domains
Class 4.1: High-mobility group domain factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
SOX2		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in osteosarcoma condition			[46]
TF Protein Name	Transcription factor SOX-2		Transcription Factor Info
Studied Phenotype	Osteosarcoma [ICD11: 2B51]
Tissue	Bone
Related DT Changes	up regulating
Experimental Material	Human osteosarcoma cells (U-2OS)
Detailed Description	Transcription factor SOX-2 (SOX2), influenced by the exogenous methotrexate, has been reported to activate the transcription of ABCB1 gene in osteosarcoma condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Class 4.2: Heteromeric CCAAT-binding factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
NFYA		Click to Show/Hide to Show 3 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colorectal cancer condition			[47]
TF Protein Name	Nuclear transcription factor Y subunit alpha		Transcription Factor Info
Affected Drug/Substrate	Oxaliplatin; Vincristine
Studied Phenotype	Colorectal cancer [ICD11: 2B91]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (HCT-8)
Detailed Description	Nuclear transcription factor Y subunit alpha (NFYA) has been reported to activate the transcription of ABCB1 gene in colorectal cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in epidermoid carcinoma condition			[31]
TF Protein Name	Nuclear transcription factor Y subunit alpha		Transcription Factor Info
Studied Phenotype	Epidermoid carcinoma [ICD11: 2C31]
Tissue	Cervix
Related DT Changes	Up regulating
Experimental Material	Human human papillomavirus-related endocervical adenocarcinoma cells (KB-3-1)
Detailed Description	Nuclear transcription factor Y subunit alpha (NFYA) has been reported to activate the transcription of ABCB1 gene in epidermoid carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Activation of ABCB1 gene in floor of mouth squamous oell carcinoma			[48]
TF Protein Name	Nuclear transcription factor Y subunit alpha		Transcription Factor Info
Studied Phenotype	Floor of mouth squamous cell carcinoma [ICD11: 2B64.0]
Tissue	Mouth
Related DT Changes	Up regulating
Experimental Material	Human floor of mouth squamous cell carcinoma cells (T-167)
Detailed Description	Nuclear transcription factor Y subunit alpha (NFYA) has been reported to activate the transcription of ABCB1 gene in floor of mouth squamous cell carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TF Superclass 6: Immunoglobulin fold
Class 6.1: Rel homology region factors		Click to Show/Hide the Full List of 2 TF(s) Regulating This DT
NFKB1		Click to Show/Hide to Show 4 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in colon cancer condition			[49]
TF Protein Name	Nuclear factor NF-kappa-B p105 subunit		Transcription Factor Info
Affected Drug/Substrate	Daunomycin
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	Up regulating
Experimental Material	Human colon adenocarcinoma cells (HCT15)
Detailed Description	Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to activate the transcription of ABCB1 gene in colon cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in osteosarcoma condition			[50]
TF Protein Name	Nuclear factor NF-kappa-B p105 subunit		Transcription Factor Info
Affected Drug/Substrate	Paclitaxel
Studied Phenotype	Osteosarcoma [ICD11: 2B51]
Tissue	Bone
Related DT Changes	up regulating
Experimental Material	Human osteosarcoma cells (U-2OS)
Detailed Description	Nuclear factor NF-kappa-B p105 subunit (NFKB1), influenced by the exogenous dioscin, has been reported to activate the transcription of ABCB1 gene in osteosarcoma condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Activation of ABCB1 gene in floor of mouth squamous oell carcinoma			[48]
TF Protein Name	Nuclear factor NF-kappa-B p105 subunit		Transcription Factor Info
Studied Phenotype	Floor of mouth squamous cell carcinoma [ICD11: 2B64.0]
Tissue	Mouth
Related DT Changes	Up regulating
Experimental Material	Human floor of mouth squamous cell carcinoma cells (T-167)
Detailed Description	Nuclear factor NF-kappa-B p105 subunit (NFKB1) has been reported to activate the transcription of ABCB1 gene in floor of mouth squamous cell carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 4	Repression of ABCB1 gene in breast cancer condition			[51]
TF Protein Name	Nuclear factor NF-kappa-B p105 subunit		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	down regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Nuclear factor NF-kappa-B p105 subunit (NFKB1), influenced by the exogenous dioscin, has been reported to repress the transcription of ABCB1 gene in breast cancer condition , which leads to a decreased expression of the drug transporter P-glycoprotein 1.
RELA		Click to Show/Hide to Show 7 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in lung squamous cell cancer condition			[6]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Affected Drug/Substrate	Adriamycin; Daunomycin
Studied Phenotype	Lung squamous cell cancer [ICD11: 2C25.2]
Tissue	Lung
Related DT Changes	Up regulating
Experimental Material	Human lung squamous cell carcinoma cells (SK-MES-1)
Detailed Description	Transcription factor p65 (RELA) has been reported to activate the transcription of ABCB1 gene in lung squamous cell cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in breast cancer condition			[52]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Affected Drug/Substrate	Doxorubicin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	up regulating
Experimental Material	Human breast cancer cells (MDA-MB-231); human breast cancer cells (MDA-MB-231)
Detailed Description	Transcription factor p65 (RELA), influenced by the exogenous bortezomib, has been reported to activate the transcription of ABCB1 gene in breast cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 3	Activation of ABCB1 gene in chronic myeloid leukemia condition			[53]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Affected Drug/Substrate	Daunorubicin
Studied Phenotype	Chronic myeloid leukemia [2B33.2]
Tissue	Blood
Related DT Changes	up regulating
Experimental Material	Human chronic myeloid leukemia cells (K-562)
Detailed Description	Transcription factor p65 (RELA), influenced by the exogenous bortezomib, has been reported to activate the transcription of ABCB1 gene in chronic myeloid leukemia condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 4	Activation of ABCB1 gene in colon cancer condition			[54]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Affected Drug/Substrate	Oxaliplatin
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	up regulating
Experimental Material	Human colon carcinoma cells (HCT 116)
Detailed Description	Transcription factor p65 (RELA), influenced by the exogenous bortezomib, has been reported to activate the transcription of ABCB1 gene in colon cancer condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 5	Activation of ABCB1 gene in floor of mouth squamous oell carcinoma			[48]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Studied Phenotype	Floor of mouth squamous cell carcinoma [ICD11: 2B64.0]
Tissue	Mouth
Related DT Changes	Up regulating
Experimental Material	Human floor of mouth squamous cell carcinoma cells (T-167)
Detailed Description	Transcription factor p65 (RELA) has been reported to activate the transcription of ABCB1 gene in floor of mouth squamous cell carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 6	Activation of ABCB1 gene in breast cancer condition			[55]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Transcription factor p65 (RELA) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 7	Repression of ABCB1 gene in colon cancer condition			[56]
TF Protein Name	Transcription factor p65		Transcription Factor Info
Affected Drug/Substrate	5-fluorouracil
Studied Phenotype	Colon cancer [ICD11: 2B90]
Tissue	Colon
Related DT Changes	down regulating
Experimental Material	Human colon carcinoma cells (HCT-116)
Detailed Description	Transcription factor p65 (RELA), influenced by the exogenous bortezomib, has been reported to repress the transcription of ABCB1 gene in colon cancer condition , which leads to a decreased expression of the drug transporter P-glycoprotein 1.
Class 6.2: STAT domain factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
STAT3		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in cervical epithelioid carcinoma condition			[57]
TF Protein Name	Signal transducer and activator of transcription 3		Transcription Factor Info
Affected Drug/Substrate	Doxorubicin
Studied Phenotype	Cervical epithelioid carcinoma [2C77.Z]
Tissue	Cervix
Related DT Changes	up regulating
Experimental Material	Human cervical epithelioid carcinoma cells (HeLaS3)
Detailed Description	Signal transducer and activator of transcription 3 (STAT3), influenced by the exogenous butyrate, has been reported to activate the transcription of ABCB1 gene in cervical epithelioid carcinoma condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in lung adenocarcinoma condition			[58]
TF Protein Name	Signal transducer and activator of transcription 3		Transcription Factor Info
Studied Phenotype	Lung adenocarcinoma [ICD11: 2C25.0]
Tissue	Lung
Related DT Changes	up regulating
Experimental Material	Human lung adenocarcinoma cells (A549)
Detailed Description	Signal transducer and activator of transcription 3 (STAT3), influenced by the exogenous butyrate, has been reported to activate the transcription of ABCB1 gene in lung adenocarcinoma condition , which leads to an increased expression of the drug transporter P-glycoprotein 1.
Class 6.3: p53 domain factors		Click to Show/Hide the Full List of 4 TF(s) Regulating This DT
mutated TP53 (p.D281G)		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in osteosarcoma condition			[42]
TF Protein Name	Cellular tumor antigen p53		Transcription Factor Info
Studied Phenotype	Osteosarcoma [ICD11: 2B51]
Tissue	Bone
Related DT Changes	Up regulating
Experimental Material	Human osteosarcoma cells (Saos-2)
Detailed Description	mutated Cellular tumor antigen p53 (mutated TP53 (p.D281G)) has been reported to activate the transcription of ABCB1 gene in osteosarcoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TP53		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in melanoma condition			[59]
TF Protein Name	Cellular tumor antigen p53		Transcription Factor Info
Studied Phenotype	Melanoma [ICD11: 2C30]
Tissue	Skin
Related DT Changes	Down regulating
Experimental Material	human melanoma cell isolates
Detailed Description	Cellular tumor antigen p53 (TP53) has been reported to repress the transcription of ABCB1 gene in melanoma condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
TP63		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in brain neuroblastoma condition			[60]
TF Protein Name	Tumor protein 63		Transcription Factor Info
Studied Phenotype	Brain neuroblastoma [ICD11: 2A00.11]
Tissue	Brain
Related DT Changes	Up regulating
Experimental Material	Human neuroblastoma cells (SK-N-AS)
Detailed Description	Tumor protein 63 (TP63) has been reported to activate the transcription of ABCB1 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TP73		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in breast cancer condition			[61]
TF Protein Name	Tumor protein p73		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	Breast cancer [ICD11: 2C60-2C6Z]
Tissue	Breast
Related DT Changes	Up regulating
Experimental Material	Human invasive breast carcinoma of no special type cells (MCF-7)
Detailed Description	Tumor protein p73 (TP73) has been reported to activate the transcription of ABCB1 gene in breast cancer condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Activation of ABCB1 gene in brain neuroblastoma condition			[60]
TF Protein Name	Tumor protein p73		Transcription Factor Info
Studied Phenotype	Brain neuroblastoma [ICD11: 2A00.11]
Tissue	Brain
Related DT Changes	Up regulating
Experimental Material	Human neuroblastoma cells (SK-N-AS)
Detailed Description	Tumor protein p73 (TP73) has been reported to activate the transcription of ABCB1 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
TF Superclass 9: beta-Barrel DNA-binding domains
Class 9.1: Cold-shock domain factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
YBX1		Click to Show/Hide to Show 2 Transcriptional Phenomena
Transcriptional Phenomenon 1	Activation of ABCB1 gene in epidermoid carcinoma condition			[31]
TF Protein Name	Y-box-binding protein 1		Transcription Factor Info
Studied Phenotype	Epidermoid carcinoma [ICD11: 2C31]
Tissue	Cervix
Related DT Changes	Up regulating
Experimental Material	Human human papillomavirus-related endocervical adenocarcinoma cells (KB-3-1)
Detailed Description	Y-box-binding protein 1 (YBX1) has been reported to activate the transcription of ABCB1 gene in epidermoid carcinoma condition, which leads to an increased expression of the drug transporter P-glycoprotein 1.
Transcriptional Phenomenon 2	Repression of ABCB1 gene in high grade ovarian serous adenocarcinoma condition			[62]
TF Protein Name	Y-box-binding protein 1		Transcription Factor Info
Studied Phenotype	High grade ovarian serous adenocarcinoma [ICD11: 2C73.03]
Tissue	Ovary
Related DT Changes	Down regulating
Experimental Material	BALB/c athymic Nu/Nu mice
Detailed Description	Y-box-binding protein 1 (YBX1) has been reported to repress the transcription of ABCB1 gene in high grade ovarian serous adenocarcinoma condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.
TF Superclass 10: Yet undefined DNA-binding domains
Class 10.1: Other factors		Click to Show/Hide the Full List of 1 TF(s) Regulating This DT
MECP2		Click to Show/Hide to Show 1 Transcriptional Phenomena
Transcriptional Phenomenon 1	Repression of ABCB1 gene in acute lymphoblastic leukemia condition			[63]
TF Protein Name	Methyl-CpG-binding protein 2		Transcription Factor Info
Affected Drug/Substrate	Adriamycin
Studied Phenotype	T acute lymphoblastic leukemia [ICD11: 2A90]
Tissue	Blood
Related DT Changes	Down regulating
Experimental Material	Human childhood T acute lymphoblastic leukemia cells (CEM-A7)
Detailed Description	Methyl-CpG-binding protein 2 (MECP2) has been reported to repress the transcription of ABCB1 gene in acute lymphoblastic leukemia condition, which leads to a decreased expression of the drug transporter P-glycoprotein 1.

References
1	CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Mol Pharmacol. 2004 Apr;65(4):906-16.
2	Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology. 2008 Nov;135(5):1636-1644.e3.
3	Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Breast Cancer Res Treat. 1999 Feb;53(3):229-40.
4	COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis. 2011 May;32(5):667-75.; 2011 May;32(5):667-75.
5	Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res. 2003 Aug 1;63(15):4527-32.
6	PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB. Cancer Chemother Pharmacol. 2010 May;65(6):1131-6.
7	Astragali radix and its main bioactive compounds activate the Nrf2-mediated signaling pathway to induce P-glycoprotein and breast cancer resistance protein. J Ethnopharmacol. 2019 Jan 10;228:82-91.; 2019 Jan 10;228:82-91.
8	Mechanisms of P-Glycoprotein Regulation Under Exogenous and Endogenous Oxidative Stress In Vitro. Acta Naturae. 2022 Jul-Sep;14(3):69-78.; 2022 Jul-Sep;14(3):69-78.
9	Aryl hydrocarbon receptor ligands increase ABC transporter activity and protein expression in killifish (Fundulus heteroclitus) renal proximal tubules. Biol Chem. 2019 Sep 25;400(10):1335-1345.; 2019 Sep 25;400(10):1335-1345.
10	Overcoming ABCB1-mediated multidrug resistance by transcription factor BHLHE40. Neoplasia. 2023 May;39:100891.
11	Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 2002 Jun 15;62(12):3387-94.
12	HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity. Mol Cancer Res. 2019 Aug;17(8):1675-1686.; 2019 Aug;17(8):1675-1686.
13	MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model. Am J Pathol. 2003 Jul;163(1):321-31.
14	Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res. 2000 Sep 1;60(17):4761-6.
15	Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells. Mol Cancer. 2010 May 8;9:102.
16	P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res. 2004 Jul;21(7):1284-93.
17	PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line. Cancer Chemother Pharmacol. 2010 Sep;66(4):765-71.
18	Regulation of drug resistance by human pregnane X receptor in breast cancer. Cancer Biol Ther. 2009 Jul;8(13):1265-72.
19	Repeated dosing of piperine induced gene expression of P-glycoprotein via stimulated pregnane-X-receptor activity and altered pharmacokinetics of diltiazem in rats. Biopharm Drug Dispos. 2012 Nov;33(8):446-54.
20	The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther. 2005 Feb;312(2):841-8.
21	St. John's wort may ameliorate 2,4,6-trinitrobenzenesulfonic acid colitis off rats through the induction of pregnane X receptors and/or P-glycoproteins. J Physiol Pharmacol. 2015 Apr;66(2):203-14.; 2015 Apr;66(2):203-14.
22	Suppression of carboxylesterases by imatinib mediated by the down-regulation of pregnane X receptor. Br J Pharmacol. 2017 Apr;174(8):700-717.; 2017 Apr;174(8):700-717.
23	A role for constitutive androstane receptor in the regulation of human intestinal MDR1 expression. Biol Chem. 2005 Jun;386(6):503-13.
24	Examination of Glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta. 2007 Oct;28(10):1004-11.
25	Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier. Am J Physiol Cell Physiol. 2008 Aug;295(2):C440-50.
26	Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes. Anticancer Drugs. 2015 Aug;26(7):706-15.; 2015 Aug;26(7):706-15.
27	NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
28	Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. Eur J Biochem. 2001 Aug;268(15):4151-7.
29	12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell Biol. 1995 Nov;15(11):6100-8.
30	Closure of the NCBI SRA and implications for the long-term future of genomics data storage. Genome Biol. 2011;12(3):402.
31	Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J Biol Chem. 2000 Jan 28;275(4):2979-85.
32	SP1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J Biol Chem. 1993 Sep 15;268(26):19505-11.
33	The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ. 1999 Jun;10(6):377-86.
34	Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance. Cancer Res. 2010 Nov 1;70(21):8726-35.
35	CDX2 regulates multidrug resistance 1 gene expression in malignant intestinal epithelium. Cancer Res. 2010 Sep 1;70(17):6767-78.
36	CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomed Pharmacother. 2022 Mar;147:112630.
37	Pituitary homeobox 2 (PITX2) protects renal cancer cell lines against doxorubicin toxicity by transcriptional activation of the multidrug transporter ABCB1. Int J Cancer. 2013 Aug 1;133(3):556-67.
38	Regulation of the MDR1 promoter by E2F1 and EAPP. FEBS Lett. 2013 May 21;587(10):1504-9.
39	Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1. Mol Pharmacol. 2010 Nov;78(5):855-64.
40	Regulation of multidrug resistance 1 (MDR1)/P-glycoprotein gene expression and activity by heat-shock transcription factor 1 (HSF1). J Biol Chem. 2000 Aug 11;275(32):24970-6.
41	Drug resistant breast cancer cells overexpress ETS1 gene. Biomed Pharmacother. 2010 Sep;64(7):458-62.
42	Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1. J Biol Chem. 2001 Oct 19;276(42):39359-67.
43	The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Mol Cell Biol. 1998 Jun;18(6):3604-11.
44	hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-169. (ID:ENSG00000085563)
45	Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer. Cancer Lett. 2019 Aug 10;457:28-39.; 2019 Aug 10;457:28-39.
46	miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL. J Clin Med. 2023 Feb 1;12(3):1177.; 2023 Feb 1;12(3):1177.
47	Role for Class I histone deacetylases in multidrug resistance. Exp Cell Res. 2012 Feb 1;318(3):177-86.
48	Lack of P-glycoprotein expression by low-dose fractionated radiation results from loss of nuclear factor-kappaB and NF-Y activation in oral carcinoma cells. Mol Cancer Res. 2008 Jan;6(1):89-98.
49	NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene. 2003 Jan 9;22(1):90-7.
50	Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-kappaB signaling. Int J Mol Med. 2017 Apr;39(4):993-1000.; 2017 Apr;39(4):993-1000.
51	Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1. Sci Rep. 2016 Jun 22;6:28403.; 2016 Jun 22;6:28403.
52	Nuclear factor-KappaB signaling inhibitors revert multidrug-resistance in breast cancer cells. Chem Biol Interact. 2021 May 1;340:109450.
53	Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib. Eur Rev Med Pharmacol Sci. 2014;18(10):1465-72.; 2014;18(10):1465-72.
54	Resveratrol induces AMPK-dependent MDR1 inhibition in colorectal cancer HCT116/L-OHP cells by preventing activation of NF-kappaB signaling and suppressing cAMP-responsive element transcriptional activity. Tumour Biol. 2015 Dec;36(12):9499-510.; 2015 Dec;36(12):9499-510.
55	Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem. 2009 Jan 30;284(5):2657-2671.
56	(-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-kappaB/miR-155-5p/MDR1 Pathway. J Agric Food Chem. 2019 Mar 6;67(9):2510-2518.; 2019 Mar 6;67(9):2510-2518.
57	Novel application of rhein and its prodrug diacerein for reversing cancer-related multidrug resistance through the dual inhibition of P-glycoprotein efflux and STAT3-mediated P-glycoprotein expression. Biomed Pharmacother. 2022 Jun;150:112995.; 2022 Jun;150:112995.
58	Sodium butyrate increases P-gp expression in lung cancer by upregulation of STAT3 and mRNA stabilization of ABCB1. Anticancer Drugs. 2018 Mar;29(3):227-233.; 2018 Mar;29(3):227-233.
59	Regulation of metastasis-related gene expression by p53: a potential clinical implication. Mol Carcinog. 1999 Jan;24(1):25-8.
60	Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain. J Biol Chem. 2005 Apr 8;280(14):13213-9.
61	deltaNp73 regulates the expression of the multidrug-resistance genes ABCB1 and ABCB5 in breast cancer and melanoma cells - a short report. Cell Oncol (Dordr). 2017 Dec;40(6):631-638.
62	Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells. Oncogene. 2007 Apr 26;26(19):2736-46.
63	Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol Cell Biol. 2002 Mar;22(6):1844-57.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Transcriptional Regulations

Visitor Map

Correspondence